Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open pilot study of oral vancomycin in pediatric primary sclerosing cholangitis
2009-018034-11Phase 4Active
- Sponsor
- Karolinska Institutet
- Start
- Jun 2011
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of vancomycin in Primary Sclerosing Cholangitis (PSC), sponsored by Karolinska Institutet. Primary endpoint: Clinical status after 1 year of oral vancomycin. Started Jun 2011; status: active.
02
Drugs
vancomycin
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on 2009-018034-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018034-11.